CEimpact Podcast
The CEimpact Podcast features two shows:
GameChangers Clinical Updates
Precept2Practice
GameChangers Clinical Update Series:
The GameChangers podcast, hosted by Rachel Maynard, PharmD, features the latest game-changing pharmacotherapy advances impacting patient care. New episodes arrive every Monday. Listeners can purchase the episode to earn CE credit at: https://www.ceimpact.com/resources/podcast/
Precept2Practice
The Precept2Practice podcast, hosted by Kathy Schott, brings you tools to mentor students and residents with confidence. New episodes arrive on the third Wednesday of every month. Preceptor By Design™ subscribers can earn CE credit for each episode.
Give us a follow, tune in regularly, and turn your drive time, coffee break, or chart review into a chance to level up your practice. CEimpact continuing education makes pharmacy learning inspiring!
Check back each week for our latest episodes.
CEimpact Podcast
Treatment of Vaso-occlusive Crisis - Some Gain, Less Pain
The recent ESCAPED study examines the treatment of Vaso-occlusive Crisis (VOC) in persons with Sickle Cell Disease (SCD). Many patients have difficulty receiving treatment due to a myriad of factors, including structural racism. Listen as Geoff examines if the ESCAPED study can shine a light on how to treat VOC in patients with SCD.
Redeem your CPE or CME credit here!
References and resources:
Lanzkron S, Little J, Wang H, et al. Treatment of Acute Pain in Adults With Sickle Cell Disease in an Infusion Center Versus the Emergency Department : A Multicenter Prospective Cohort Study. Ann Intern Med. 2021 Jul 6. doi: 10.7326/M20-7171. Epub ahead of print. PMID: 34224261.
Continuing Education Information:
Learning Objectives:
1. Describe the guideline goals for treatment of Vaso-occlusive Crisis (VOC) to a specific patient
2. Discuss the results of the ESCAPED study in relation to outcomes
0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-286-H01-P
Initial release date: 8/24/21
Expiration date: 8/24/22
Complete CPE & CME details can be found here.